Email This Article
Headlines & Perspectives
Genzyme Boosts Revenue
By
Robert Steyer
10/20/04 - 11:21 AM EDT
The biotech company beats expectations and guides in line.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,243.04 | 1,093.24 | 2,151.74 | 34.84 |
Oil *
77.36
|
|
UP
16.10
|
UP
0.17
|
DOWN
2.32
|
DOWN
0.02
|
10 Yr
3.48%
SPDR Gold
108.20
|
|
+0.16%
|
+0.02%
|
-0.11%
|
-0.06%
|
Data delayed 20 minutes |


Connect with TheStreet